Brief: MaxCyte Q3 Revenue USD 6.4 Million Vs. IBES Estimate USD 8.37 Million
05/11/2025 13:05
Nov 05 (Reuters) - MaxCyte Q3 cash & investments USD 158 million.
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview